文献速递甲状腺疾病

多灶性并非甲状腺乳头状癌的独立预后因素:倾向性评分匹配分析

Multifocality Is not an Independent Prognostic Factor in Papillary Thyroid Cancer: A Propensity Score-Matching Analysis.
PubMed 文献 · Thyroid · 2019-03-15

该研究回顾性分析两个三级医疗中心1039例甲状腺乳头状癌(PTC)患者,中位随访10.1年,多灶组534例(51.4%),单灶组505例(48.6%)。多灶组年龄更大、男性更多、腺外侵犯、淋巴结转移、III/IV期及ATA复发风险更高,且1年持续性疾病率(26.6% vs. 16.4%,p<0.001)、随访期间复发率(12.7% vs. 6.6%,p=0.002)和总死亡率(15.5% vs. 9.7%,p=0.002)均更高。但经倾向性评分匹配校正混杂因素后,复发、末次随访持续性疾病和死亡率均无显著差异,提示多灶性仅是更广泛疾病的标志,而非独立预后因素。

要点

  • 多灶性PTC患者初诊时疾病更广泛,但并非独立预后因素。
  • 倾向性评分匹配后,多灶性与复发、持续性疾病和死亡率无显著关联。
  • 多灶性不应单独作为更积极治疗的依据。

核心结论

  • 多灶性是PTC患者初诊时更广泛疾病的标志,但不是长期结局的独立预后因素。

研究设计与样本

  • 回顾性队列研究,纳入两个三级医疗中心1039例连续PTC患者,中位随访10.1年,采用两种倾向性评分模型及多因素分析。

主要发现

  • 多灶组534例(51.4%),单灶组505例(48.6%)。
  • 多灶组年龄更大、男性更多、腺外侵犯更多、淋巴结转移更多、III/IV期更多、ATA复发风险更高。
  • 多灶组1年持续性疾病率26.6% vs. 16.4%(p<0.001),随访期间复发率12.7% vs. 6.6%(p=0.002),总死亡率15.5% vs. 9.7%(p=0.002)。
  • 倾向性评分匹配校正混杂因素后,复发、末次随访持续性疾病和死亡率无显著差异。

临床怎么用

  • 临床评估PTC预后时,不应仅凭多灶性判定为高危而过度治疗。
  • 多灶性提示初诊时疾病可能更广泛,需全面评估腺外侵犯和淋巴结转移等情况。

局限性

  • 回顾性研究设计可能存在选择偏倚和未测量混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy. Despite its low mortality rate, the disease has a recurrence rate of up to 30%. The mainstay of treatment for PTC is surgery, followed by radioiodine ablation and thyroxine therapy in appropriately selected patients. PTC can appear as a unifocal solitary tumor, but also as two or more anatomically separate foci. A great deal of controversy surrounds the significance of multifocality as a prognostic factor, and it is considered a poor prognostic factor that prompts more aggressive treatment. The aim of this study was to investigate the prognostic value of tumor multifocality on disease recurrence and mortality in PTC patients. METHODS: Data of 1039 consecutive PTC patients from two tertiary medical centers were reviewed. The baseline characteristics and short- and long-term outcome were analyzed to evaluate the prognostic significance of multifocal disease. The application of two different propensity score models followed multivariate analysis. RESULTS: The median follow-up was 10.1 years, and 534 (51.4%) patients had multifocal disease and 505 (48.6%) unifocal disease. Patients with the multifocal disease were significantly older, were more frequently male, had more extrathyroidal extension, more lymph node metastases, more advanced disease (stage III/IV), and a higher American Thyroid Association recurrence risk. Multifocal PTC patients had more persistence at one year (26.6% vs. 16.4%; p < 0.001), more recurrence during follow-up (12.7% vs. 6.6%; p = 0.002), and a higher overall mortality rate (15.5% vs. 9.7%; p = 0.002). However, there were no significant differences in recurrence, last-visit persistency, and mortality rates when adjusting for confounding variables by using propensity score matching. CONCLUSION: This propensity score-matching study provides the best available data to support the assertion that multifocality in PTC patients is a marker of more extensive disease at presentation, but not an independent prognostic factor for long-term outcomes.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Geron Y, Benbassat C, Shteinshneider M, et al. Multifocality Is not an Independent Prognostic Factor in Papillary Thyroid Cancer: A Propensity Score-Matching Analysis. Thyroid. 2019. PMID: 30799769. doi:10.1089/thy.2018.0547

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。